JOAQUIN LIZAOLA: Open Payments
NPI 1821661182 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 8 payments from 7 companies in 2025. Trend: 2023 $266 · 2024 $789 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $134 |
| Actelion Pharmaceuticals US, Inc. | 1 | $133 |
| Novartis Pharmaceuticals Corporation | 1 | $98 |
| Kestra Medical Technology Services, Inc. | 2 | $88 |
| Novo Nordisk Inc | 1 | $25 |
| Abbott Laboratories | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $10 |
Products named: OPSUMIT, LEQVIO, Assure WCD, Wegovy, CARDIOMEMS, LifeVest.
Industry payments across WA — which companies pay providers there.
